Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines

Publication | Closed Access

DOI

Citations

References

2008

Year

Roman Prymula, Roman Chlíbek, Miroslav Špliňo, Eva Kaliskova, Igor Kohl, Patricia Lommel, Lode Schuerman

Vaccine

VaccinationVaccine DevelopmentType B11-Valent Pneumococcal VaccinePolio VirusVaccine TargetImmunologyVirologyInfection ControlVaccine DesignPolyvalent VaccineMedicine